Fidelity Select Portfolios · net assets $6.29B · 241 holdings as of August 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 95.8% · STIV: 3.4% · EP: 0.7% · DBT: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $47.7M | $132M | $83.7M |
| Reinvestment | $0 | $0 | $162 |
| Redemptions | $93.3M | $59.8M | $65.3M |
| Net realized gain (non-derivative) | $147M | $48.1M | $70.2M |
| Net unrealized appreciation (non-derivative) | $561M | $-252M | $404M |
The three months of the reporting period, as filed; month 3 ends August 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Abbvie Inc EC | $654M | 10.40% |
| Krystal Biotech Inc EC | $648M | 10.30% |
| Amgen Inc EC | $439M | 6.98% |
| Moderna Inc EC | $220M | 3.49% |
| Fidelity Revere Street Trust STIV | $215M | 3.43% |
| Insmed Inc EC | $151M | 2.41% |
| Revolution Medicines Inc EC | $151M | 2.40% |
| Argenx Se EC | $146M | 2.32% |
| Praxis Precision Medicines Inc. EC | $144M | 2.29% |
| Ascendis Pharma A/s EC | $126M | 2.01% |
| Natera Inc EC | $108M | 1.72% |
| Jazz Pharmaceuticals PLC EC | $103M | 1.64% |
| Biogen Inc EC | $98.9M | 1.57% |
| Alnylam Pharmaceuticals Inc EC | $95.8M | 1.52% |
| Scholar Rock Holding Corp EC | $93.7M | 1.49% |
| Protagonist Therapeutics Inc EC | $89.8M | 1.43% |
| Ucb Sa EC | $77.2M | 1.23% |
| Roivant Sciences Ltd EC | $70.3M | 1.12% |
| Bridgebio Pharma Inc EC | $68.6M | 1.09% |
| Kymera Therapeutics Inc EC | $66.1M | 1.05% |
| Twist Bioscience Corp EC | $65.2M | 1.04% |
| Candel Therapeutics Inc EC | $63.6M | 1.01% |
| Vaxcyte Inc EC | $59.5M | 0.95% |
| Immunome Inc EC | $58.4M | 0.93% |
| Corcept Therapeutics Inc EC | $57.4M | 0.91% |
| Tango Therapeutics Inc EC | $57.1M | 0.91% |
| Axsome Therapeutics Inc EC | $56.5M | 0.90% |
| Cogent Biosciences Inc EC | $56.2M | 0.89% |
| Madrigal Pharmaceuticals Inc EC | $53M | 0.84% |
| Travere Therapeutics Inc EC | $52.9M | 0.84% |
| Dyne Therapeutics Inc EC | $52.4M | 0.83% |
| Oruka Therapeutics Inc EC | $52.1M | 0.83% |
| Kiniksa Pharmaceuticals International PLC EC | $50.1M | 0.80% |
| Amylyx Pharmaceuticals Inc EC | $49.6M | 0.79% |
| Stoke Therapeutics Inc EC | $46.3M | 0.74% |
| Erasca Inc EC | $44.6M | 0.71% |
| Dianthus Therapeutics Inc EC | $44.4M | 0.71% |
| Celcuity Inc EC | $42.7M | 0.68% |
| United Therapeutics Corp Del EC | $42.2M | 0.67% |
| Arrivent Biopharma Inc EC | $39.7M | 0.63% |
| Trevi Therapeutics Inc EC | $39.4M | 0.63% |
| Spyre Therapeutics Inc EC | $36M | 0.57% |
| Enliven Therapeutics Inc EC | $35.8M | 0.57% |
| Disc Medicine Inc EC | $35.8M | 0.57% |
| Galderma Group Ag EC | $35M | 0.56% |
| Arrowhead Pharmaceuticals Inc EC | $33.7M | 0.54% |
| Biohaven Ltd EC | $33.3M | 0.53% |
| Vor Biopharma Inc EC | $31.5M | 0.50% |
| Nextcure Inc EC | $30.9M | 0.49% |
| Celldex Therapeutics Inc EC | $30.9M | 0.49% |
| Annexon Inc EC | $30.5M | 0.49% |
| Viridian Therapeutics Inc EC | $30.3M | 0.48% |
| Relay Therapeutics Inc EC | $30.2M | 0.48% |
| Edgewise Therapeutics Inc EC | $29.2M | 0.46% |
| Ionis Pharmaceuticals Inc EC | $28.8M | 0.46% |
| Cg Oncology Inc EC | $28.7M | 0.46% |
| Silence Therapeutics PLC EC | $27.6M | 0.44% |
| Xenon Pharmaceuticals Inc EC | $26.2M | 0.42% |
| Ideaya Biosciences Inc EC | $25.6M | 0.41% |
| Solid Biosciences Inc EC | $25M | 0.40% |
Showing top 60 of 241 holdings.
Loading...
